IMMUCELL CORP /DE/ Quarterly Retained Earnings (Accumulated Deficit) in USD from Q4 2010 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The cumulative amount of the reporting entity's undistributed earnings or deficit.
Summary
Immucell Corp /De/ quarterly Retained Earnings (Accumulated Deficit) history and growth rate from Q4 2010 to Q2 2024.
  • Immucell Corp /De/ Retained Earnings (Accumulated Deficit) for the quarter ending June 30, 2024 was -$14M, a 40.8% decline year-over-year.
Retained Earnings (Accumulated Deficit), Quarterly (USD)
Retained Earnings (Accumulated Deficit), YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 -$14M -$4.05M -40.8% Jun 30, 2024 10-Q 2024-08-13
Q1 2024 -$12.4M -$3.9M -45.6% Mar 31, 2024 10-Q 2024-05-14
Q4 2023 -$12M -$5.77M -92.7% Dec 31, 2023 10-Q 2024-08-13
Q3 2023 -$10.9M -$6.3M -138% Sep 30, 2023 10-Q 2023-11-13
Q2 2023 -$9.93M -$6.02M -154% Jun 30, 2023 10-Q 2023-08-10
Q1 2023 -$8.55M -$5.32M -165% Mar 31, 2023 10-Q 2023-05-11
Q4 2022 -$6.23M -$2.49M -66.7% Dec 31, 2022 10-K 2024-04-01
Q3 2022 -$4.56M -$752K -19.7% Sep 30, 2022 10-Q 2022-11-21
Q2 2022 -$3.91M +$51K +1.29% Jun 30, 2022 10-Q/A 2022-11-21
Q1 2022 -$3.23M +$876K +21.4% Mar 31, 2022 10-Q/A 2022-11-21
Q4 2021 -$3.74M -$78.3K -2.14% Dec 31, 2021 10-K 2023-03-29
Q3 2021 -$3.81M +$36.4K +0.95% Sep 30, 2021 10-Q 2021-11-15
Q2 2021 -$3.96M -$434K -12.3% Jun 30, 2021 10-Q 2021-08-12
Q1 2021 -$4.1M -$1.34M -48.6% Mar 31, 2021 10-Q 2021-05-13
Q4 2020 -$3.66M -$1.02M -38.7% Dec 31, 2020 10-K 2022-03-30
Q3 2020 -$3.85M -$1.52M -65.4% Sep 30, 2020 10-Q 2020-11-12
Q2 2020 -$3.53M -$1.7M -93.2% Jun 30, 2020 10-Q 2020-08-12
Q1 2020 -$2.76M -$1.56M -130% Mar 31, 2020 10-Q 2020-05-13
Q4 2019 -$2.64M -$1.3M -96.5% Dec 31, 2019 10-K 2021-03-30
Q3 2019 -$2.33M -$2.04M -701% Sep 30, 2019 10-Q 2019-11-12
Q2 2019 -$1.83M -$1.78M -4406% Jun 30, 2019 10-Q 2019-08-12
Q1 2019 -$1.2M -$1.96M -258% Mar 31, 2019 10-Q 2019-05-13
Q4 2018 -$1.34M -$2.32M -237% Dec 31, 2018 10-K 2020-03-27
Q3 2018 -$290K -$1.46M -125% Sep 30, 2018 10-Q 2018-11-13
Q2 2018 -$40.5K -$1.55M -103% Jun 30, 2018 10-Q 2018-08-13
Q1 2018 $758K -$974K -56.2% Mar 31, 2018 10-Q 2018-05-14
Q4 2017 $979K -$168K -14.7% Dec 31, 2017 10-K 2019-03-22
Q3 2017 $1.17M +$56.8K +5.09% Sep 30, 2017 10-Q 2017-11-13
Q2 2017 $1.51M +$431K +39.8% Jun 30, 2017 10-Q 2017-08-14
Q1 2017 $1.73M +$640K +58.7% Mar 31, 2017 10-Q 2017-05-11
Q4 2016 $1.15M +$508K +79.6% Dec 31, 2016 10-K 2018-03-29
Q3 2016 $1.12M +$767K +219% Sep 30, 2016 10-Q 2016-11-10
Q2 2016 $1.08M +$1.08M Jun 30, 2016 10-Q 2016-08-11
Q1 2016 $1.09M +$1.19M Mar 31, 2016 10-Q 2016-05-11
Q4 2015 $639K +$1.21M Dec 31, 2015 10-K 2017-03-30
Q3 2015 $350K +$1.06M Sep 30, 2015 10-Q 2015-11-12
Q2 2015 -$1.43K* +$714K Jun 30, 2015 10-Q 2015-08-13
Q1 2015 -$95.5K +$325K +77.3% Mar 31, 2015 10-Q 2015-05-12
Q4 2014 -$575K -$167K -41% Dec 31, 2014 10-K 2016-03-25
Q3 2014 -$705K -$448K -175% Sep 30, 2014 10-Q 2014-11-12
Q2 2014 -$716K -$401K -128% Jun 30, 2014 10-Q 2014-08-13
Q1 2014 -$421K -$100K -31.3% Mar 31, 2014 10-Q 2014-05-14
Q4 2013 -$407K +$117K +22.4% Dec 31, 2013 10-K 2015-03-26
Q3 2013 -$257K +$251K +49.5% Sep 30, 2013 10-Q 2013-11-13
Q2 2013 -$314K +$130K +29.3% Jun 30, 2013 10-Q 2013-08-13
Q1 2013 -$320K +$139K +30.3% Mar 31, 2013 10-Q 2013-05-14
Q4 2012 -$525K +$89.5K +14.6% Dec 31, 2012 10-K 2014-03-26
Q3 2012 -$508K +$106K +17.2% Sep 30, 2012 10-Q 2012-11-13
Q2 2012 -$444K +$41.8K +8.59% Jun 30, 2012 10-Q/A 2012-09-07
Q1 2012 -$460K Mar 31, 2012 10-Q 2012-05-14
Q4 2011 -$614K -$410K -200% Dec 31, 2011 10-K 2013-03-28
Q3 2011 -$614K Sep 30, 2011 10-Q 2011-11-14
Q2 2011 -$486K Jun 30, 2011 10-Q 2011-08-15
Q4 2010 -$205K Dec 31, 2010 10-K 2012-03-27
* An asterisk sign (*) next to the value indicates that the value is likely invalid.